ReviewCurrent heart failure reports2025
Predictors of Left Ventricular Reverse Remodeling in Heart Failure with Reduced Ejection Fraction.
Review in Current heart failure reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Age-Related Concentric Remodeling and Sex-Dependent Dimensional Variation in Left Ventricular Geometry: A Cardiac Magnetic Resonance Study.Tomography (Ann Arbor, Mich.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewWhile left ventricular (LV) remodeling has been associated with poor prognosis in heart failure with reduced ejection, a variable degree of LV remodeling can be reversed upon the removal of the initial insult and with appropriate therapies. Hence, better prediction of LV reverse remodeling would not only help prognostically, but also could illuminate potential therapeutic targets. Herein, we provide a comprehensive review on the latest evidence on the predictors of LV reverse remodeling. RECENT
findingsSeveral predictors of LV reverse remodeling have been identified including certain baseline parameters of underlying cardiomyopathy, myocardial structure and function assessed by multi-modality imaging, and biomarkers. Beyond improving clinical outcomes, many of the established and emerging heart failure therapies have been also demonstrated to promote reverse remodeling, likely reflective of the mechanistic underpinning of their therapeutics benefits. With the ongoing development of novel diagnostics and therapies of heart failure, our understanding of LV reverse remodeling continues to evolve. Furthermore, with the growing evidence between reverse remodeling and clinical outcomes, reverse remodeling may prove to be a clinically useful marker of myocardial recovery and potential therapeutic target.
Indexed as
Identifiers
41236670What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.